Filing Details

Accession Number:
0001209191-15-022573
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-04 19:18:15
Reporting Period:
2015-03-02
Filing Date:
2015-03-04
Accepted Time:
2015-03-04 19:18:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504465 J Jacob Plattner C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Senior Vp, Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-02 6,475 $43.99 45,000 No 4 S Indirect See Footnote
Common Stock Disposition 2015-03-02 400 $44.60 44,600 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,020 Direct
Footnotes
  1. This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.44 to $44.41, inclusive.
  3. These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.
  4. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.55 to $44.65, inclusive.